While its "AAA" credit rating, robust free cash flow, and low-debt profile offer a defensive haven in a volatile market, the stock now sits at a valuation peak ...

(Reuters) - Johnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis treatment Stelara until January 2025 could make the drug a larger contributor ...

Johnson & Johnson's stock hits a 52-week high, but key drug patent risks and a lower Wall Street price target suggest downside. Learn more about JNJ stock here.

J&J has signed its latest Stelara patent settlement with Fresenius Kabi and Formycon, granting the biosimilar partners a U.S. license date for their drug beginning "no later than April 15, 2025," ...

Q4 2025 Management View CEO John Rademacher highlighted that Option Care Health served over 315,000 unique patients in 2025, completing more than 2.5 million infusion events, and reinforced the ...

Option Care Health (NASDAQ:OPCH) executives said the company delivered 2025 results in line with figures it had pre-announced in January and reaffirmed its 2026 outlook, while continuing to navigate ...

Evernorth's Accredo specialty pharmacy will offer biosimilars for the popular immunotherapy Stelara at $0 for eligible patients, the company announced Thursday. The interchangeable biosimilar will be ...

Under assault from newer therapies in the anti-inflammatory market, Johnson & Johnson has focused on expanding Stelara beyond dermatology—and Monday, it took another big step in that direction. The ...

Johnson & Johnson recently launched Stelara for the treatment of adult patients with moderate to severe plaque psoriasis. Although Stelara is entering a crowded treatment room for psoriasis, this ...

Johnson & Johnson’s (NYSE:JNJ) Stelara could become the #2 drug in the Crohn’s Disease market over the next few years. Crohn’s Disease causes inflammation of the digestive tract. J&J’s top selling ...

Savings and financial assistance programs are available for Stelara, such as Stelara withMe and J&J withME. Stelara might cost less with insurance than without it. Savings options are available for ...